WO2009141781A1 - Process for the preparation of beta-santalol and derivatives thereof - Google Patents

Process for the preparation of beta-santalol and derivatives thereof Download PDF

Info

Publication number
WO2009141781A1
WO2009141781A1 PCT/IB2009/052048 IB2009052048W WO2009141781A1 WO 2009141781 A1 WO2009141781 A1 WO 2009141781A1 IB 2009052048 W IB2009052048 W IB 2009052048W WO 2009141781 A1 WO2009141781 A1 WO 2009141781A1
Authority
WO
WIPO (PCT)
Prior art keywords
group
compound
formula
mixture
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2009/052048
Other languages
English (en)
French (fr)
Inventor
Charles Fehr
Magali Vuagnoux
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Firmenich SA
Original Assignee
Firmenich SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Firmenich SA filed Critical Firmenich SA
Priority to CN200980118062XA priority Critical patent/CN102036941B/zh
Priority to AT09750238T priority patent/ATE527228T1/de
Priority to US12/936,325 priority patent/US7902393B2/en
Priority to EP09750238A priority patent/EP2282985B1/en
Priority to JP2011510079A priority patent/JP5550637B2/ja
Publication of WO2009141781A1 publication Critical patent/WO2009141781A1/en
Priority to IL209363A priority patent/IL209363A/en
Anticipated expiration legal-status Critical
Priority to US13/012,567 priority patent/US8119826B2/en
Priority to IL226276A priority patent/IL226276A0/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/05Alcohols containing rings other than six-membered aromatic rings
    • C07C33/14Alcohols containing rings other than six-membered aromatic rings containing six-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/132Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
    • C07C29/136Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
    • C07C29/147Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of carboxylic acids or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/36Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal
    • C07C29/38Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/30Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation with halogen containing compounds, e.g. hypohalogenation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/51Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
    • C07C45/511Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups
    • C07C45/512Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups the singly bound functional group being a free hydroxyl group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/62Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by hydrogenation of carbon-to-carbon double or triple bonds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/72Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups
    • C07C45/74Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups combined with dehydration
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/72Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups
    • C07C45/75Reactions with formaldehyde
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/28Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/283Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group by hydrogenation of unsaturated carbon-to-carbon bonds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/30Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/333Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
    • C07C67/343Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/36Systems containing two condensed rings the rings having more than two atoms in common
    • C07C2602/42Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms

Definitions

  • R represents a Me or Et group
  • said compound is in the form of any one of its stereoisomers or mixture thereof.
  • the invention concerns also the compound (I) as well as its precursors and the process to manufacturing compound (I). Furthermore, it concerns also the use of compound (I) for the synthesis of ⁇ -santalol or of derivatives thereof.
  • the compounds of formula (I) are novel compounds, and are useful starting materials for the preparation of ⁇ -santalol, and derivatives thereof, in a short and effective manner.
  • the ⁇ -santalol, and derivatives thereof, are well known perfuming ingredients, some of which of particular relevance. Therefore, there is always a need for alternative synthesis to produce them.
  • EP 10213 however said process, besides the fact that it is very long, requires many chlorinated intermediates (not optimal for a use in perfumery) and provides a very low yield (about 13%) for the preparation of the unsaturated aldehyde (II) of the present invention (see below);
  • a first object of the present invention is a compound of formula
  • R represents a Me or Et group
  • R a represents a hydrogen atom or a Si(R b ) 3 or (R C ) 2 COH group
  • R b representing Ci_s group or a phenyl group
  • R c representing a Ci_s group or a phenyl group.
  • ⁇ -santalol an important perfuming ingredient
  • derivatives thereof can be advantageously prepared starting from an enynol of formula (I-a) wherein R a is a hydrogen atom, i.e. a compound of formula
  • a compound (I) or (I-a) wherein R is Me is the preferred embodiment, since it is a direct precursor of ⁇ -santalol.
  • Said compound (I) can be advantageously prepared from the compounds (I-a) wherein R a is not a hydrogen atom.
  • a second object of the present invention concerns a process for the preparation of a compound (I), as defined above, comprising the following steps: a) reacting 2-R-3-methylene-bicyclo[2.2.1]heptane, wherein R has the same meaning as for compound (I), with a compound of formula R a -C ⁇ CCHO, wherein R a represents a Si(R b ) 3 or (R C ) 2 COH group, R b and R c representing, independently from each other, Ci_s group or a phenyl group, in the presence of a Al, B or Sn derivative Lewis acid as catalyst ("ene” reaction), to obtain a compound of formula (I-a) wherein R a represents a Si(R b ) 3 or (R C ) 2 COH group, R b and R c representing, independently from each other, Ci_s group or a phenyl group; and b) treating the obtained compound (I-a) with a suitable base or a fluorine
  • the starting material of the above process is 2endo-methyl-3-methylene-bicyclo[2.2.1]heptane, in an optically active or racemic form.
  • the catalysts necessary for an "ene reaction” are well known by a person skilled in the art, however one may cite, as non limiting examples, the following compounds: Me 2 AlCl, EtAlCl 2 , SnCl 4 or BF 3 .
  • the bases of fluorine salt necessary for step b) are well known by a person skilled in the art, however one may cite, as non limiting examples, the following compounds: KOH, borax (Na 2 B 4 O ? ) or KF.
  • R b is defined as for compound (I-a);
  • Ar represents a phenyl group optionally substituted by one, two or three Me, Et CF 3 , OMe or OEt;
  • R d represents t-Bu, a phenyl group, a benzyl group or a 5-Me-furyl group
  • R e represents a hydrogen atom, a Ci-C 3 alkyl group or a benzyl group
  • R f represents t-Bu, a phenyl group, a benzyl group; (to obtain S-R-bicycloP ⁇ .ljhept-S-ene ⁇ exo-carbaldehyde);
  • b' reducing the Diels Alder adduct obtained in step a') into a saturated alcohol, and optionally converting said alcohol into an ester, carbonate or a sulfonate;
  • c' converting said alcohol, ester, carbonate or sulphonate, into the desired product.
  • Step a' is a known reaction and a person skilled in the art is able to apply its standard knowledge to perform them (e.g. see MacMillan et al. in WO 03/002491 or in J.Am.Chem.Soc. 2005, 127, 11616 or see Hayashi et al. in Angew.Chem.Int.ed. 2008, 47,
  • Steps b') and c') are well known reactions and a person skilled in the art is able to apply its standard knowledge to perform them. Examples of how performing said process is provided in the Example part of the description.
  • ester, carbonate or sulfonate it is meant the usual meaning in the art, i.e. that the oxygen atom of said saturated alcohol is bonded to an acyl, alkoxycarbonyl or sulfonate group (e.g. a Ci_ 7 group).
  • R is a methyl group
  • enynol (I) has been found to be a useful precursor of ⁇ -santalol, and derivatives thereof. Indeed enynol (I) can be used for the preparation of an aldehyde (II), as defined below, which is known to be an important intermediate in the preparation of ⁇ -santalol and derivatives thereof.
  • a second object of the present invention is a process for the preparation of a compound of formula
  • M represents Zn(II), Cu(I) or Ag(I), n represents an integer from 0 to 4, L represents a C 1 -C 4 nitrile, COHSCN, or di-nitrile, or a Cs-Cs pyridine derivative, and Z a weakly or non coordinating anion.
  • said M(L) n Z salt is Cu(L) 4 Z, wherein L is Ci-C 4 nitrile, or a AgZ salt.
  • Z is a R 4 S(V, wherein R 4 is a chlorine or fluorine atom or an Ci-Cs alkyl, fluoroalkyl or fluoroaryl group, BF 4 -, PF 6 -, SbCl 6 ", SbF 6 -, or BR 5 4 " , wherein R 5 is a phenyl group optionally substituted by one to five groups such as halide atoms or methyl or CF 3 groups.
  • M is Ag(I) then Z may also represent a nitrate or a perchlorate.
  • Z is BF 4 -, PF 6 -, SbCl 6 " , C 6 F 5 SO 3 " , BPh 4 " , CF 3 SO 3 " or yet B[3,5-(CF 3 ) 2 C 6 H 4 ] 4 -, more preferably BF 4 " .
  • an alkaline salt of the anion Z can be also added, as additive, an alkaline salt of the anion Z.
  • a salt of formula KZ or CsZ can be added.
  • the transformation of (I) into (II), in any of its embodiments, is preferably carried out in the presence of solvent.
  • solvent Non-limiting examples of such a solvent are esters, aromatic hydrocarbons, chlorinated solvents and mixtures thereof. More preferably, the solvent is toluene or 1,2-dichloroethane and mixtures thereof.
  • the temperature, at which the transformation of (I) into (II) according to the invention can be carried out in any of its embodiments, is comprised between 0 0 C and 150 0 C, preferably between 40 0 C and 70 0 C.
  • a person skilled in the art is also able to select the preferred temperature as a function of the melting and boiling point of the starting and final products and/or an eventual solvent.
  • the salt M(L) n Z can be added to the reaction medium in a large range of concentrations.
  • the salt concentration will be comprised between 0.01 and 0.10 molar equivalents.
  • the optimum concentration of the M(L) n Z will depend on the nature of the latter and on the desired reaction time.
  • the additive can be added to the reaction medium in a large range of concentrations.
  • the additive concentration will be comprised between 10 and 120 %, relative to the weight of the salt.
  • the compounds (I-a), (I) or (II) can be in the form of any one of its stereoisomers or mixture thereof.
  • stereoisomer it is intended any diastereomer, enantiomer, racemate or carbon-carbon isomer of configuration E or Z.
  • compound (I-a) is in the form of a mixture of stereoisomers comprising more than 50% (w/w) of the (1R,4S) stereoisomer, i.e. a compound having the absolute configuration as shown in formula (I-a')
  • said compound (I) consists essentially in the compound (I-a').
  • compound (I) is in the form of a mixture of stereoisomers comprising more than 50% (w/w) of the (1R,4S) stereoisomer, i.e. a compound having the absolute configuration as shown in formula (F)
  • said compound (I) consists essentially in the compound (F).
  • compounds (I) one may cite l-[-3- methylbicyclo[2.2.1]hept-2-en-2-yl]-3-butyn-2-ol or its stereoisomer l-[(lR,4S)-3- methylbicyclo[2.2.1]hept-2-en-2-yl]-3-butyn-2-ol.
  • compound (II) is in the form of a mixture of isomers comprising more than 50% (w/w) of the 2-endo-R configuration.
  • said compound (II) can be in the form of a mixture of stereoisomers comprising more than 50% (w/w) of the (1S,2S,4R) stereoisomer, i.e. a compound having the absolute configuration as shown in formula (IF)
  • said compound (II) consists essentially in the compound (IF).
  • compound (I) is a useful starting material for the preparation of ⁇ -santalol or a derivative thereof
  • the present invention concerns also the use of a compound (I), as intermediate, in the synthesis of a compound of formula (III) as defined herein below.
  • the invention concerns also a process for obtaining a compound of formula ( ⁇ -santalol or derivatives)
  • R represents a Me or Et group
  • R 1 represents a hydrogen atom or a Me or Et group
  • X represents a CH 2 OR 2 , CHO or a CH(OR 3 ) 2 group, R 2 representing a hydrogen atom, a C 1 -C 3 alkyl, alkenyl or acyl group, R 3 representing, when taken separately, a C 1 -C 3 alkyl, alkenyl or acyl group or, when taken together, a C 2 -C 5 alkanediyl group; and the dotted lines represents a single or double bond, said compound being in the form of any one of its stereoisomers or mixture thereof; said process comprising the following steps: 1) transforming an enynol of formula (I), as defined above, into an aldehyde of formula (II), as defined above, by a process as described above; and T) transforming the aldehyde of formula (II), into a compound of formula (III), as defined above.
  • R represents a methyl group.
  • R 1 represents a methyl or ethyl group.
  • R 2 represents a hydrogen atom or a C 1 -C 3 acyl group.
  • R 3 represents, when taken separately, a methyl or ethyl group or, when taken together, a C 2 -C 4 alkanediyl group.
  • the compounds (III) can be in the form of any one of its stereoisomers or mixture thereof.
  • stereoisomer it is intended any diastereomer, enantiomer, racemate or carbon-carbon isomer of configuration E or Z.
  • compound (III) is in the form of a mixture of isomers comprising more than 50% (w/w) of the 2-endo-R configuration.
  • said compound (III) can be in the form of a mixture of stereoisomers comprising more than 50% (w/w) of the (1S,2S,4R), or even (2Z,1S,2S,4R), stereoisomer, i.e. a compound having the absolute configuration as shown in formula (HF)
  • said compound (III) consists essentially in the compound (HF)-
  • ⁇ -santalol As typical examples of compounds (III) one may cite the following: ⁇ -santalol, (-)- ⁇ -santalol (i.e (2Z)-2-methyl-5-[(lS,2R,4R)-2-methyl-3- methylenebicyclo[2.2.1]hept-2-yl]-2-penten-l-ol), ⁇ -santalal, ⁇ -santalyl benzoate, ⁇ - santalyl butyrate, ⁇ -santalyl formate, ⁇ -santalyl proprionate.
  • the first step of said process is as defined above.
  • the Wittig-hydroxyalkylation addition can be performed according to the method reported by R.Snowden et al. in Helvetica Chemica Acta, 1981, 64, 25.
  • the Wittig addition allows obtaining directly compound (III) where X represents CH 2 OR 2 , wherein R 2 is a hydrogen atom or some acyl groups. If a compound (III) with a different meaning of R is desired, then said compound can be obtained by converting the alcohol (III) (X being CH 2 OH) with any standard method as well known by a person skilled in the art. For example, an aldehyde of formula (III) can be obtained by oxidation of the alcohol (III), or an ester (III) can be obtained by esterification of said alcohol (III), etc.
  • the aldehyde (II) can be converted into the compound (HF), see below, by performing the following reactions: a) reducing (hydrogenation) the aldehyde (II) into and aldehyde of formula (IV)
  • R 4 represents a C 1 -C 3 alkyl, alkenyl or acyl group or a C3-C8 silyl group; d) reducing the enolate (VI) into a compound (VII)
  • Step e) is described as optional only because many of the compounds (VII) are already included in formula (III), and therefore, depending on the desired compound (III) the last step is not necessary.
  • said compounds (IV) to (VII) possess a configuration corresponding to the one described above for compounds (IF) or (HF).
  • Steps a) to e) can be performed according to standard methods well known by a person skilled in the art.
  • step a) or b) may cite the following method for each step: step a) or b) according to EP 10213; step c) according to Simmons et al. in Helv.Chim.Acta, 1988, 71, 1000, or WO 2005/037243; and step d) according to Shibasaki et al., in J.Org.Chem., 1988, 53, 1227 (where is reported the [1,4] hydrogenation of a dienol acetate derivative) or according to WO 08/120175.
  • step a) or b) according to EP 10213
  • step c) according to Simmons et al. in Helv.Chim.Acta, 1988, 71, 1000, or WO 2005/037243
  • step d) according to Shibasaki et al., in J.Org.Chem., 1988, 53, 1227 (where is reported the [1,4] hydrogenation of a dienol acetate derivative) or according to WO 08
  • the orange mixture was hydrolyzed with aqueous HCl 5%.
  • the aqueous layer was extracted twice with Et 2 O, and the combined organic layers were washed twice with H 2 O.
  • the aqueous fraction was extracted twice with Et 2 O and the combined organic fractions were washed with H 2 O, brine, dried over Na 2 SO 4 and filtered off.
  • the solvents were removed under vacuum to give a crude which was further purified by bulb to bulb distillation under reduced pressure to afford the desired compound (42.24 g, 95% purity) in 86% yield.
  • Ethynylmagnesium bromide in THF (0.5 M, 210.0 ml, 105.0 mmol) was placed in a reactor under a nitrogen atmosphere at room temperature and (3-Methyl- bicyclo[2.2.1]hept-2-en-2-yl)-acetaldehyde (12.15 g, 80.9 mmol) in THF (200 ml) was introduced over a 90 minutes period and the mixture turned orange. The mixture was further stirred at room temperature for 30 minutes and was hydrolyzed with aqueous HCl 5% at room temperature.
  • Trimethylsilylethyne (5.0 ml, 36.10 mmol) in THF (25.0 ml) was dropwsise added to a solution of EtMgBr in THF (IM, 44.0 ml, 44.0 mmol) at 10-15 0 C under nitrogen.
  • IM EtMgBr
  • IM EtMgBr
  • Et 2 O Et 2 O
  • Me 2 AlCl (IM in hexanes, 1.1 ml, 1.1 mmol) was dropwise added to a solution of trimethylsilyl-propynal (154.0 mg, 1.22 mmol) and 2-endo-methyl-3-methylene- bicyclo[2.2.1]heptane (140.0 mg, 1.15 mmol) in dichloromethane (5.0 ml) at -78°C under nitrogen. The mixture was stirred at -78°C for 15 minutes and was hydrolyzed with aqueous HCl 5%. The temperature was then slowly allowed to increase to room temperature and extracted twice with CH 2 Cl 2 .
  • Pd/CaCO 3 (5% w/w, 93.0 mg) was placed into a two neck round bottom flask in methanol (30 ml) and the atmosphere was purged with N 2 before adding 3-(2-methyl-3- methylene-bicyclo[2.2.1]hept-2-exo-yl)-propen-l-al (1.886 g, 10.70 mmol). The atmosphere was further purged with nitrogen followed with hydrogen at room temperature. The mixture was stirred at room temperature under one atmosphere of hydrogen for 4.5 hours.
  • the methyl-norbornenols were hydrogenated (5% of 10% Pd on C; Et 2 O, 99% yield).
  • the compound thus obtained was diluted in pentane (5%) and pyrolyzed at 415°C through a 3 m column under a nitrogen flow to afford the optically active endo-enriched title compound in ca.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PCT/IB2009/052048 2008-05-20 2009-05-18 Process for the preparation of beta-santalol and derivatives thereof Ceased WO2009141781A1 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
CN200980118062XA CN102036941B (zh) 2008-05-20 2009-05-18 用于制备β-檀香醇及其衍生物的方法
AT09750238T ATE527228T1 (de) 2008-05-20 2009-05-18 Verfahren zur herstellung von beta-santalol und derivaten davon
US12/936,325 US7902393B2 (en) 2008-05-20 2009-05-18 Process for the preparation of β-santalol and derivatives thereof
EP09750238A EP2282985B1 (en) 2008-05-20 2009-05-18 Process for the preparation of beta-santalol and derivatives thereof
JP2011510079A JP5550637B2 (ja) 2008-05-20 2009-05-18 β−サンタロールおよびその誘導体を製造するための方法
IL209363A IL209363A (en) 2008-05-20 2010-11-16 A process for making beta-centanol and its derivatives
US13/012,567 US8119826B2 (en) 2008-05-20 2011-01-24 Process for the preparation of beta-santalol and derivatives thereof
IL226276A IL226276A0 (en) 2008-05-20 2013-05-09 Process for the preparation of beta-santanol and its derivatives

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08104028.9 2008-05-20
EP08104028 2008-05-20

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US12/936,325 A-371-Of-International US7902393B2 (en) 2008-05-20 2009-05-18 Process for the preparation of β-santalol and derivatives thereof
US13/012,567 Continuation US8119826B2 (en) 2008-05-20 2011-01-24 Process for the preparation of beta-santalol and derivatives thereof

Publications (1)

Publication Number Publication Date
WO2009141781A1 true WO2009141781A1 (en) 2009-11-26

Family

ID=39885154

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2009/052048 Ceased WO2009141781A1 (en) 2008-05-20 2009-05-18 Process for the preparation of beta-santalol and derivatives thereof

Country Status (8)

Country Link
US (2) US7902393B2 (https=)
EP (2) EP2386537B1 (https=)
JP (2) JP5550637B2 (https=)
CN (1) CN102036941B (https=)
AT (1) ATE527228T1 (https=)
ES (2) ES2401986T3 (https=)
IL (2) IL209363A (https=)
WO (1) WO2009141781A1 (https=)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012110375A1 (en) 2011-02-16 2012-08-23 Firmenich Sa Intermediates for the preparation of beta-santalol
WO2013001027A1 (en) 2011-06-30 2013-01-03 Firmenich Sa Process for the preparation of beta-santalol
WO2013001026A1 (en) 2011-06-30 2013-01-03 Firmenich Sa Process for the preparation of beta-santalol
EP4678622A1 (en) 2024-07-07 2026-01-14 Studiengesellschaft Kohle gGmbH Process for preparing an enantiomeric pure diels-alder adduct

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9701926B2 (en) * 2013-11-11 2017-07-11 Firmenich Sa Compound with a woody odour
US9958504B2 (en) 2014-06-20 2018-05-01 Duracell U.S. Operations, Inc. Primary alkaline battery with integrated in-cell resistances
EP3227255B1 (en) * 2014-12-02 2018-11-07 Firmenich SA Intermediates and process for the preparation of sandalwood oil building blocks
CN117843453A (zh) * 2022-09-30 2024-04-09 中国科学院大连化学物理研究所 一种2-亚龙脑烯基丁醇的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3662008A (en) * 1969-05-21 1972-05-09 Procter & Gamble Process for preparing beta-santalol from 3-methylnorcamphor
US4223167A (en) * 1978-02-14 1980-09-16 Fritzsche Dodge & Olcott Inc. Processes for preparing β-santalol, β-santalene dihydro-β-santalol and related compounds
DE2843838A1 (de) 1978-10-07 1980-04-24 Basf Ag Bicyclische verbindungen, verfahren zu deren herstellung und deren verwendung
JPS5738730A (en) * 1980-08-14 1982-03-03 Kuraray Co Ltd Cis-pentene derivative and its preparation
JPS5742659A (en) * 1980-08-28 1982-03-10 Kuraray Co Ltd Bicyclo 2 2 1 heptane derivative and its preparation
US4510319A (en) * 1982-07-01 1985-04-09 Fritzsche Dodge & Olcott Inc. Functionalization of terminal trisubstituted alkenes and derivatives thereof
FR2621912B1 (fr) * 1987-10-16 1990-03-02 Oreal Nouveaux derives du norbornane, leur procede de preparation et compositions cosmetique et medicamenteuse les contenant
JP2929943B2 (ja) * 1994-09-07 1999-08-03 ダイソー株式会社 カルシトリオール中間体及びその製法
AU2002320231A1 (en) 2001-06-29 2003-03-03 California Institute Of Technology Enantioselective transformation of alpha, beta-unsaturated aldehydes using chiral organic catalysts
DE10348062A1 (de) 2003-10-16 2005-05-19 Symrise Gmbh & Co. Kg Kurzkettige Enolester als Riechstoff-Prekursoren
US7112700B1 (en) * 2005-04-14 2006-09-26 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Efficient and economic asymmetric synthesis of nootkatone, tetrahydronootkatone, their precursors and derivatives
US8003838B2 (en) 2007-04-03 2011-08-23 Firmenich Sa 1,4-hydrogenation of dienes with Ru complexes

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
A. KROTZ ET AL., TET. ASYM, vol. 1, 1990, pages 537
KRESCHMAR, ERMAN: "The total synthesis and geometric configuration of dl-beta-santalol", TETRAHEDRON LETTERS, vol. 1, 1970, pages 41 - 44, XP002502909 *
KRETSCHMAT H.C. ET AL., TETRAHEDRON LETTERS, vol. 1, 1970, pages 41
KROTZ, HELMCHEN: "Total syntheses of sandalwood fragrances: (Z)-and (E)-beta-santalol and their enantiomers, ent-beta-santalene", TETRAHEDRON: ASYMMETRY, vol. 1, no. 8, 1990, pages 537 - 540, XP002502910 *

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103384655A (zh) * 2011-02-16 2013-11-06 弗门尼舍有限公司 用于制备β-檀香醇的中间体
WO2012110375A1 (en) 2011-02-16 2012-08-23 Firmenich Sa Intermediates for the preparation of beta-santalol
US8822733B2 (en) 2011-02-16 2014-09-02 Firmenich Sa Intermediates for the preparation of beta-santalol
JP2014522825A (ja) * 2011-06-30 2014-09-08 フイルメニツヒ ソシエテ アノニム β−サンタロールの製造方法
US20140187811A1 (en) * 2011-06-30 2014-07-03 Firmenich Sa Process for the preparation of beta-santalol
WO2013001026A1 (en) 2011-06-30 2013-01-03 Firmenich Sa Process for the preparation of beta-santalol
WO2013001027A1 (en) 2011-06-30 2013-01-03 Firmenich Sa Process for the preparation of beta-santalol
JP2014523889A (ja) * 2011-06-30 2014-09-18 フイルメニツヒ ソシエテ アノニム β−サンタロールの製造方法
US9056826B2 (en) 2011-06-30 2015-06-16 Firmenich Sa Process for the preparation of beta-santalol
US9156770B2 (en) 2011-06-30 2015-10-13 Firmenich Sa Process for the preparation of beta-santalol
US9212112B1 (en) 2011-06-30 2015-12-15 Firmenich Sa Process for the preparation of beta-santalol
EP4678622A1 (en) 2024-07-07 2026-01-14 Studiengesellschaft Kohle gGmbH Process for preparing an enantiomeric pure diels-alder adduct
WO2026012663A1 (en) 2024-07-07 2026-01-15 Studiengesellschaft Kohle Ggmbh Process for preparing an enantiomeric pure diels-alder adduct

Also Published As

Publication number Publication date
EP2282985A1 (en) 2011-02-16
IL226276A0 (en) 2013-06-27
EP2386537B1 (en) 2013-01-16
EP2386537A3 (en) 2012-01-11
EP2386537A2 (en) 2011-11-16
ES2401986T3 (es) 2013-04-26
US20110028750A1 (en) 2011-02-03
IL209363A0 (en) 2011-01-31
EP2282985B1 (en) 2011-10-05
JP5717893B2 (ja) 2015-05-13
CN102036941A (zh) 2011-04-27
CN102036941B (zh) 2013-07-31
JP5550637B2 (ja) 2014-07-16
JP2014098019A (ja) 2014-05-29
US8119826B2 (en) 2012-02-21
JP2011520950A (ja) 2011-07-21
ATE527228T1 (de) 2011-10-15
ES2372911T3 (es) 2012-01-27
US20110118497A1 (en) 2011-05-19
US7902393B2 (en) 2011-03-08
IL209363A (en) 2014-04-30

Similar Documents

Publication Publication Date Title
US8119826B2 (en) Process for the preparation of beta-santalol and derivatives thereof
EP1122236B1 (en) Process for producing 6-methyl-3-hepten-2-one, and process for producing phyton or isophytol
US9452961B2 (en) (6R,10R)-6,10,14-trimetylpentadecan-2-one prepared from 6,10-dimetylundec-5-en-2-one or 6,10-dimetylundeca-5,9-dien-2-one
JP2023538721A (ja) 3-(シクロヘクス-1-エン-1-イル)プロパナール誘導体を製造するための方法および中間体
EP2675776B1 (en) Intermediates for the preparation of beta-santalol
JP5410417B2 (ja) 有機化合物
JP5901757B2 (ja) β−サンタロールの製造方法
Saudan 85 Years of Catalysis at Firmenich
Speicher et al. Bryophyte Constituents; 5: Synthesis of Taylorione
EP3164377B1 (en) Prins reaction on hindered substrates
Yamashita et al. Organic synthesis via dialkylhydrazones. Part 9.. ALPHA.-Alkylation of. ALPHA.,. BETA.-Unsaturated Aldehyde Dimethylhydrazones Accompanied with the Double Bond Migration to. BETA.,. GAMMA..
Kula et al. Reconstruction of lavandulol carbon skeleton based on limonene. Synthesis of isotetrahydrolavandulol
Kawamura et al. Asymmetric α-Alkylation of Phenylacetates Using 2-Alkylamino-2′-hydroxy-1, 1′-binaphthyls as Chiral Auxiliaries
EP2726448A1 (en) Process for the preparation of beta-santalol
JP2009514872A (ja) シクロペンタノン誘導体の製造方法

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200980118062.X

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09750238

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2009750238

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 12936325

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 3703/KOLNP/2010

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 2011510079

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 226276

Country of ref document: IL